{"id":"W2636042323","doi":"10.1016/j.ejca.2017.05.031","title":"Health-related quality of life results from the phase III CheckMate 067 study","year":2017,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Cancer Foundation","funders":"Genentech; Astellas Pharma; Merck Sharp and Dohme; Eisai; National Cancer Institute; Dendreon Pharmaceuticals; Incyte; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; LEO Pharma; Prometheus; Helsinn; Roche; EMD Serono; Novartis; GlaxoSmithKline; Merck; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer","keywords":"Phase (matter); Medicine; Chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004533736,0.0001231809,0.0005540178,0.00003628701,0.0002261694,0.00004123026,0.0004166954,0.00001723267,0.0001983032],"category_scores_gemma":[0.0004778501,0.0000719735,0.000200449,0.00006317498,0.0001661811,0.00009920105,0.00004937744,0.0003171049,0.000005530509],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007548539,"about_ca_system_score_gemma":0.0003804408,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003654414,"about_ca_topic_score_gemma":0.0002593835,"domain_scores_codex":[0.9970673,0.000675281,0.001516012,0.0001381824,0.0004468671,0.0001563843],"domain_scores_gemma":[0.9959161,0.0001003016,0.002953855,0.000630511,0.0002479302,0.0001512652],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.2047776,0.002636679,0.05529668,0.00008869505,0.005808993,0.000427832,0.03370361,0.00002904855,0.02646929,0.00001193663,0.07759091,0.5931588],"study_design_scores_gemma":[0.05964125,0.001757861,0.9087711,0.0005051081,0.0001315411,0.00001244487,0.00120074,0.000006784348,0.0005455046,0.000006212472,0.0273211,0.000100333],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.970482,0.008948975,0.0000136703,0.01682101,0.000801545,0.0002536942,0.00008983203,0.000007636873,0.002581645],"genre_scores_gemma":[0.9965693,0.001245419,0.00003372097,0.0009705707,0.0005340966,7.459208e-7,0.000003099932,0.00002233671,0.0006207478],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8534744,"threshold_uncertainty_score":0.5524405,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09786343728687633,"score_gpt":0.4043122046986372,"score_spread":0.3064487674117609,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}